根据名称进行药物检索

Timoptic-XE Ocumeter与重症肌无力

Timoptic-XE Ocumeter与重症肌无力安全配伍检测的结果。

检测结果:

Timoptic-XE Ocumeter <> 重症肌无力

现实性: 23.07.2019 评论家: 医学副博士Shkutko P.M., in

通过权威的信息来源 Drugs.com、Rxlist.com、Webmd.com、Medscape.com，在进行所选药物与这种伴发疾病互相作用检测时，发现一些会产生负面影响或对身体危害的禁忌症及副作用。

用户:

局部应用的β-肾上腺素受体阻断剂(又名的β受体阻滞剂)有系统地吸收，有可能产生临床上的重大系统性影响，甚至在低或无法检测的血浆水平。在神经和肌肉骨骼系统，测试封锁可能会加强肌肉软弱符合某些肌无力的症状，例如复视、上睑下垂，和一般的弱点。几个β受体阻滞剂有关，很少与恶化的肌肉软弱患者中预先存在重症肌无力或肌无力症状。

来源

"Product Information. OptiPranolol (metipranolol)." Bausch and Lomb, Tampa, FL.
Confavreux C, Charles N, Aimard G "Fulminant myasthenia gravis soon after initiation of acebutolol therapy." Eur Neurol 30 (1990): 279-81
Choi KL, Wat MS, Ip TP, Kung AWC, Lam KSL "Phaeochromocytoma associated with myasthenia gravis precipitated by propranolol treatment." Aust N Z J Med 25 (1995): 257
"Product Information. Betagan Liquifilm (levobunolol)." Allergan Inc, Irvine, CA.
"Product Information. Timoptic (timolol ophthalmic)." Merck & Co, Inc, West Point, PA.
Herishanu Y, Rosenberg P "Beta-blockers and myasthenia gravis." Ann Intern Med 83 (1975): 834-5
"Product Information. Ocupress (carteolol ophthalmic)" Ciba Vision Ophthalmics, Duluth, GA.
Berstein LP, Henkind P "Additional information on adverse reactions to timolol." Am J Ophthalmol 92 (1981): 295-6
Benjamin KW "Toxicity of ocular medications." Int Ophthalmol Clin 19 (1979): 199-255
"Product Information. Betoptic (betaxolol ophthalmic)." Alcon Laboratories Inc, Fort Worth, TX.
Coppeto JR "Timolol-associated myasthenia gravis." Am J Ophthalmol 98 (1984): 244-5
Verkijk A "Worsening of myasthenia gravis with timolol maleate eyedrops." Ann Neurol 17 (1985): 211-2
"Product Information. Betaxon (levobetaxolol ophthalmic)" Alza, Palo Alto, CA.